Small public and private drug developers are experiencing a wave of aggressive financing, while biotech stocks of all sizes extended their rally into a fourth week.
Marie Daghlain
Advertisement
Articles by Marie Daghlain
Advertisement
Latest Updated Articles
- Upstart Biotechs Rake in the Cash as Sector Rally Continues
Published: September 27th 2010 | Updated:
Advertisement
Advertisement
Trending on Medical Economics
1
2025 state of claims: Lessons from successful AI deployments
2
Survey: Practices turn to AI to ease billing delays and revenue cycle pain
3
2025 state of claims: Why more docs aren't using AI for claims
4
2025 state of claims: The most urgent need for providers to address
5
